PMI
This issue of the Scientific Update reviews key milestones from this fall, featuring the results of our latest completed clinical trial - the Exposure Response Study on the Tobacco Heating System (THS).
Read this issue to learn how this study lends further support to the conclusion that switching completely to THS presents less risk of harm than continuing to smoke.
This issue also reviews the latest technological updates to two of our product platforms, and highlights some exciting new results on the Carobon Heated Tobacco Product (CHTP), our second heated tobacco product still in development. Following in the footsteps of the previous issue, we've introduced a new section that reviews independent research from around the world on THS and the wider category of products that do not burn tobacco.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.